Fujifilm Launches the EB-710US, a Novel Next-Generation, Balloon-less Endobronchial Ultrasound (EBUS) Bronchoscope for Pulmonary Care

Innovative design improves visibility in the lung periphery while eliminating challenges associated with balloons used during EBUS procedures

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, today announced the launch of the EB-710US Ultrasound Bronchoscope, a novel next-generation endobronchial ultrasound (EBUS) solution designed to streamline workflow and enhance imaging performance for pulmonologists and healthcare systems. The new scope will be demonstrated at booth #1815 at the American Thoracic Society Conference (ATS), May 18-20 in Orlando, Florida.

The EB-710US introduces a novel balloon-less design and enables precise tissue apposition, supported by a 180° acute bending angulation, a slim 6.4mm distal end, and a narrow 5.9mm insertion tube for enhanced maneuverability and access. The balloon-less design of the scope helps to reduce infection risks associated with the balloon – such as residual contamination after reprocessing and biofilm formation – while also eliminating the added cost of disposable balloons. Additionally, traditional EBUS scopes rely on a balloon at the tip to create consistent contact between the ultrasound probe and the airway wall. The balloon has to be carefully attached and checked to make sure there are no air bubbles. Even small bubbles can interfere with ultrasound transmission, so staff must spend extra time preparing and verifying the setup before each procedure. With the introduction of Fujifilm's EB-710US to the U.S. market, now there is no need to manually attach or position a balloon for the procedure. Clinicians save considerable time during procedure preparation and can be assured of a clear ultrasound image with ample tissue contact and exceptional tissue depth visualization.

“Pulmonologists have long balanced the need for high-quality imaging with the practical challenges of procedure efficiency and reprocessing,” said Tai Fujita, Senior Vice President, Endoscopy Division, FUJIFILM Healthcare Americas Corporation. “With our new balloon-less EBUS scope, we’re removing unnecessary complexity while delivering exceptional ultrasound performance and simplifying workflow. Fujifilm’s EB-710US is rooted in listening to our clinician partners and reflects our commitment to advancing pulmonary care through smarter, safer technology. The EB-710US reflects that commitment by addressing key challenges in EBUS procedures - reducing complexity while elevating image quality.”

At the core of the EB-710US is Fujifilm’s leading-edge high performance ultrasound transducer, engineered to deliver enhanced resolution and deep penetration, producing a clear, detailed ultrasound image. The scope also features several competitive design features to improve access and visibility into the lung periphery, including:

• Acute 180° upward and 90° downward angulation
• Slim 6.4mm distal end and 5.9mm insertion tube for enhanced maneuverability
• Shortened transducer to help improve mucosal contact
• A continuous, unobstructed view of the needle to help ensure accurate puncture alignment
• A wide 120° field of view to improve visibility during procedures

In published reports, physicians document success using the EB-710US to access challenging mediastinal and peripheral targets without a balloon. 1-3

Individuals attending ATS will have the opportunity to get hands-on with the latest scope at Fujifilm booth #1815.

1. Kapp C, Thiboutot J, Wang, D, et al. Quality of lymph node visualization using a novel slim linear EBUS bronchoscope versus a conventional linear EBUS bronchoscope: a crossover, single-blinded cadaveric study. CHEST Pulmonary. 2025;100202.
2. Watanabe H, Oki M, Shinohara Y, Toshihiro O, Imaeda Y, Iwakoshi A. EBUS-TBNA for lung cancer in the apical segment of the right upper lobe using a new EBUS scope. Respir Med Case Rep. 2026;59:102368.
3. Takigawa Y, Sato K, Matsuoka S, et al. Usefulness of novel balloon-less convex probe bronchoscope for diagnosing and staging of lung cancer via EBUS-TBNA and EUS-B-FNA. Respirol Case Rep. 2026;14(2):e70506.

About Fujifilm

FUJIFILM Healthcare Americas Corporation is a comprehensive healthcare company that has an extensive range of technology and expertise in the detection, diagnosis, and treatment of diseases. Fujifilm’s innovative portfolio includes solutions spanning diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in-vitro diagnostics. The Non-Destructive Testing group delivers radiography solutions to ensure high accuracy inspection of transportation infrastructure, and assets within aerospace, and oil and gas industries.

The company is headquartered in Lexington, Massachusetts. For more information on healthcare offerings, please visit healthcaresolutions-us.fujifilm.com, and for NDT portfolio, please visit https://www.fujifilm.com/us/en/business/industrial-materials/non-destructive-testing.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: https://holdings.fujifilm.com/en.